Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use
Crossref DOI link: https://doi.org/10.1007/s40267-018-0567-2
Published Online: 2018-10-12
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A.
Text and Data Mining valid from 2018-10-12
Article History
First Online: 12 October 2018